U.S. Science Summit: "Who will shape the future of Bio?" with Recursion President & CEO Najat Khan

The future of medicine relies on integrating artificial intelligence with deep biological insights to decode human health and accelerate drug discovery. By treating biology as a complex, non-linear system rather than a series of isolated targets, AI-driven platforms can significantly reduce the time required to bring innovative therapies to patients. Success in this field demands a new generation of "bilingual" professionals who possess both scientific and technical expertise, enabling them to connect disparate data points effectively. Beyond technical innovation, the industry must prioritize transparent communication to rebuild public trust and foster inclusive leadership cultures. Leaders must remain data-driven, focusing on rigorous, high-impact projects while championing diversity through initiatives that support career re-entry and equitable professional development. Ultimately, the goal is to improve both lifespan and healthspan by transforming how we understand and treat disease.